Accenture and Tokyo Women’s Medical University to conduct joint research
The FINANCIAL — Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients. Dr. Kazunari Tanabe, Director and Professor of Urology, Tokyo Women’s Medical
Latest comments